Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Zaia

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Biochemistry|October 24, 2001
Posttranslational modifications to human bone sialoprotein determined by mass spectrometryJ Zaia, R Boynton, D Heinegård, et al.
Biochemistry|September 20, 2000
Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor betaX Cheng, R N Cole, J Zaia, et al.
Biochemical and Biophysical Research Communications|November 22, 2001
The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cellsF Barry, R Boynton, M Murphy, et al.
Protein Science : a Publication of the Protein Society|November 25, 1998
Monitoring metal ion flux in reactions of metallothionein and drug-modified metallothionein by electrospray mass spectrometryJ Zaia, D Fabris, D Wei, et al.
Immunology Letters|April 1, 1987
Decay accelerating factor (DAF) peptide sequences share homology with a consensus sequence found in the superfamily of structurally related complement proteins and other proteins including haptoglobin, factor XIII, beta 2-glycoprotein I, and the IL-2 receptorA Nicholson-Weller, J Zaia, M G Raum, et al.
Chemical Research in Toxicology|November 1, 1994
Enantiospecificity of covalent adduct formation by benzo[a]pyrene anti-diol epoxide with human serum albuminB W Day, P L Skipper, J Zaia, et al.
Biochemical and Biophysical Research Communications|November 5, 1999
The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)F P Barry, R E Boynton, S Haynesworth, et al.
Antisense Research and Development|January 1, 1991
Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agentsJ J Rossi, D Elkins, N Taylor, et al.
Biochemistry|March 5, 1996
A binding site for chlorambucil on metallothioneinJ Zaia, L Jiang, M S Han, et al.
Cancer|August 10, 2000
High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapyA Molina, A Y Krishnan, A Nademanee, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Biochemistry|October 24, 2001
Posttranslational modifications to human bone sialoprotein determined by mass spectrometryJ Zaia, R Boynton, D Heinegård, et al.
Biochemistry|September 20, 2000
Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor betaX Cheng, R N Cole, J Zaia, et al.
Biochemical and Biophysical Research Communications|November 22, 2001
The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cellsF Barry, R Boynton, M Murphy, et al.
Protein Science : a Publication of the Protein Society|November 25, 1998
Monitoring metal ion flux in reactions of metallothionein and drug-modified metallothionein by electrospray mass spectrometryJ Zaia, D Fabris, D Wei, et al.
Immunology Letters|April 1, 1987
Decay accelerating factor (DAF) peptide sequences share homology with a consensus sequence found in the superfamily of structurally related complement proteins and other proteins including haptoglobin, factor XIII, beta 2-glycoprotein I, and the IL-2 receptorA Nicholson-Weller, J Zaia, M G Raum, et al.
Chemical Research in Toxicology|November 1, 1994
Enantiospecificity of covalent adduct formation by benzo[a]pyrene anti-diol epoxide with human serum albuminB W Day, P L Skipper, J Zaia, et al.
Biochemical and Biophysical Research Communications|November 5, 1999
The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105)F P Barry, R E Boynton, S Haynesworth, et al.
Antisense Research and Development|January 1, 1991
Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agentsJ J Rossi, D Elkins, N Taylor, et al.
Biochemistry|March 5, 1996
A binding site for chlorambucil on metallothioneinJ Zaia, L Jiang, M S Han, et al.
Cancer|August 10, 2000
High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapyA Molina, A Y Krishnan, A Nademanee, et al.
Pageof 3